Every year the American Society of Plastic Surgeons (ASPS) published a national count of cosmetic and reconstructive procedures. Those reports are no longer online. Below are the headline figures from each one: totals, the top five surgeries and injectables, average surgeon fees, and who had them.
Click a year for that report's full headline figures. 2021 is missing because ASPS did not publish a report for it. Starting with 2022, ASPS counts most surgeries from its member surgeons only and stopped publishing a combined cosmetic total, so the 2022 to 2024 rows are not comparable with earlier years (see how the method changed).
| Year | Total cosmetic procedures | Cosmetic surgical | Minimally invasive | Top surgery | Top minimally invasive |
|---|---|---|---|---|---|
| 2024 | Not published | 1,585,878 | 28,243,407 | Liposuction 349,728 | Botulinum toxin injections 9,883,711 |
| 2023 | Not published | 1,575,244 | 25,442,640 | Liposuction 347,782 | Botulinum toxin injections 9,480,949 |
| 2022 | Not published | 1,498,361 | 23,672,269 | Liposuction 325,669 | Botulinum toxin injections 8,736,591 |
| 2020 | 15,595,955 | 2,314,720 | 13,281,235 | Nose reshaping (rhinoplasty) 352,555 | Botulinum toxin injections 4,401,536 |
| 2019 | 18,428,665 | 2,678,302 | 15,750,363 | Nose reshaping (rhinoplasty) 362,299 | Botulinum toxin injections 5,043,057 |
| 2018 | 17,721,671 | 1,811,740 | 15,909,931 | Breast augmentation 313,735 | Botulinum toxin injections 7,437,378 |
| 2017 | 17,504,950 | 1,790,832 | 15,714,118 | Breast augmentation 300,378 | Botulinum toxin injections 7,230,967 |
| 2016 | 17,192,816 | 1,780,987 | 15,411,829 | Breast augmentation 290,467 | Botulinum toxin injections 7,056,255 |
| 2015 | 15,908,330 | 1,706,106 | 14,202,224 | Breast augmentation 279,143 | Botulinum toxin injections 6,757,198 |
| 2014 | 15,622,866 | 1,677,478 | 13,945,388 | Breast augmentation 286,254 | Botulinum toxin injections 6,673,608 |
| 2013 | 15,116,353 | 1,668,420 | 13,447,933 | Breast augmentation 290,224 | Botulinum toxin injections 6,321,160 |
The 2019 bar is the restated 2019 total that ASPS published in 2020 with a broader projection method; it is the baseline the 2020 report compares against. ASPS has not published a comparable combined total since 2020.
ASPS counted 1,585,878 cosmetic surgical procedures in 2024, up 1% from 2023, and 28,243,407 minimally invasive procedures. Liposuction was the most performed cosmetic surgery (349,728), and neuromodulator injections such as Botox led minimally invasive procedures (9,883,711).
| # | Procedure | Procedures |
|---|---|---|
| 1 | Liposuction | 349,728up 1% vs 2023 |
| 2 | Breast augmentation | 306,196up 1% vs 2023 |
| 3 | Tummy tuck (abdominoplasty) | 171,064up 1% vs 2023 |
| 4 | Breast lift (mastopexy) | 153,616no change vs 2023 |
| 5 | Eyelid surgery (blepharoplasty) | 120,755no change vs 2023 |
| # | Procedure | Procedures |
|---|---|---|
| 1 | Botulinum toxin injections (Botox, Dysport, Xeomin and similar) | 9,883,711up 4% vs 2023 |
| 2 | Hyaluronic acid fillers | 5,331,426up 1% vs 2023 |
| 3 | Skin resurfacing (chemical peels, laser resurfacing, dermabrasion, microdermabrasion) | 3,703,305up 6% vs 2023 |
| 4 | Skin treatments with lasers (hair removal, IPL, tattoo and leg vein lasers) | 3,112,056no change vs 2023 |
| 5 | Lip augmentation with injectables | 1,449,565up 1% vs 2023 |
| Procedure | Fee range |
|---|---|
| Breast augmentation | $4,575 to $8,000 |
| Breast lift (mastopexy) | $6,500 to $11,000 |
| Liposuction | $4,300 to $7,500 |
| Tummy tuck (abdominoplasty) | $8,000 to $13,500 |
| Nose reshaping (rhinoplasty) | $7,500 to $12,500 |
| Eyelid surgery (upper blepharoplasty) | $3,000 to $5,500 |
| Eyelid surgery (lower blepharoplasty) | $3,709 to $6,500 |
| Facelift | $12,000 to $19,000 |
In 2024 ASPS switched from a single average fee to a projected range, and published fee ranges for surgical procedures only.
| Age | Surgical | Minimally invasive |
|---|---|---|
| 19 and under | 23,3481% of surgical | 263,3421% of minimally invasive |
| 20 to 29 | 144,4429% of surgical | 975,2973% of minimally invasive |
| 30 to 39 | 365,88123% of surgical | 3,627,20413% of minimally invasive |
| 40 to 54 | 572,81936% of surgical | 10,793,63938% of minimally invasive |
| 55 to 69 | 374,26324% of surgical | 7,209,43726% of minimally invasive |
| 70 and over | 76,2225% of surgical | 611,3232% of minimally invasive |
Women had 94% of cosmetic surgical procedures (1,458,177) and 93% of minimally invasive procedures (21,858,296). Men had 6% (98,798) and 7% (1,621,946).
ASPS printed a 1.5% change for the minimally invasive total, but the 2024 total includes two categories counted for the first time (HA fillers for lip augmentation, 1,589,502, and prescribed weight loss medication, 837,485), so we do not show a year over year change for that total.
ASPS counted 1,575,244 cosmetic surgical procedures in 2023, up 5% from 2022, and 25,442,640 minimally invasive procedures. Liposuction was the most performed cosmetic surgery (347,782), and neuromodulator injections such as Botox led minimally invasive procedures (9,480,949).
| # | Procedure | Procedures |
|---|---|---|
| 1 | Liposuction | 347,782up 7% vs 2022 |
| 2 | Breast augmentation | 304,181up 2% vs 2022 |
| 3 | Tummy tuck (abdominoplasty) | 170,110up 5% vs 2022 |
| 4 | Breast lift (mastopexy) | 153,600up 7% vs 2022 |
| 5 | Eyelid surgery (blepharoplasty) | 120,747up 5% vs 2022 |
| # | Procedure | Procedures |
|---|---|---|
| 1 | Botulinum toxin injections (Botox, Dysport, Xeomin and similar) | 9,480,949up 9% vs 2022 |
| 2 | Hyaluronic acid fillers | 5,294,603up 8% vs 2022 |
| 3 | Skin resurfacing (chemical peels, laser resurfacing, dermabrasion, microdermabrasion) | 3,501,696up 5% vs 2022 |
| 4 | Skin treatments with lasers (hair removal, IPL, tattoo and leg vein lasers) | 3,101,772up 6% vs 2022 |
| 5 | Lip augmentation with injectables | 1,439,291up 4% vs 2022 |
| Procedure | Average fee |
|---|---|
| Breast augmentation | $4,875 |
| Breast lift (mastopexy) | $6,816 |
| Liposuction | $4,711 |
| Tummy tuck (abdominoplasty) | $8,174 |
| Nose reshaping (rhinoplasty) | $7,637 |
| Eyelid surgery (upper blepharoplasty) | $3,359 |
| Eyelid surgery (lower blepharoplasty) | $3,876 |
| Facelift | $11,395 |
| Botulinum toxin injection | $435 |
| Hyaluronic acid filler | $715 |
National average surgeon/physician fee. Excludes anesthesia, operating room facilities and other related expenses.
| Age | Surgical | Minimally invasive |
|---|---|---|
| 19 and under | 23,0871% of surgical | 260,8511% of minimally invasive |
| 20 to 29 | 143,1949% of surgical | 962,8854% of minimally invasive |
| 30 to 39 | 363,91524% of surgical | 3,545,48716% of minimally invasive |
| 40 to 54 | 568,22137% of surgical | 10,491,60046% of minimally invasive |
| 55 to 69 | 372,46224% of surgical | 6,979,91631% of minimally invasive |
| 70 and over | 75,8325% of surgical | 578,4323% of minimally invasive |
Women had 94% of cosmetic surgical procedures and 93% of minimally invasive procedures. Men had 6% and 7%.
Compared with 2022 under the same method. Counts marked by ASPS as member surgeon counts cover ASPS Member Surgeons only.
ASPS counted 1,498,361 cosmetic surgical procedures in 2022, up 19% from 2019, and 23,672,269 minimally invasive procedures. Liposuction was the most performed cosmetic surgery (325,669), and neuromodulator injections such as Botox led minimally invasive procedures (8,736,591).
| # | Procedure | Procedures |
|---|---|---|
| 1 | Liposuction | 325,669up 23% vs 2019 |
| 2 | Breast augmentation | 298,568up 4% vs 2019 |
| 3 | Tummy tuck (abdominoplasty) | 161,948up 37% vs 2019 |
| 4 | Breast lift (mastopexy) | 143,364up 30% vs 2019 |
| 5 | Eyelid surgery (blepharoplasty) | 115,261up 13% vs 2019 |
| # | Procedure | Procedures |
|---|---|---|
| 1 | Botulinum toxin injections (Botox, Dysport, Xeomin and similar) | 8,736,591up 73% vs 2019 |
| 2 | Hyaluronic acid fillers | 4,883,419up 70% vs 2019 |
| 3 | Skin resurfacing (chemical peels, laser resurfacing, dermabrasion, microdermabrasion) | 3,322,292 |
| 4 | Skin treatments with lasers (hair removal, IPL, tattoo and leg vein lasers) | 2,915,199 |
| 5 | Lip augmentation with injectables | 1,378,631 |
| Procedure | Average fee |
|---|---|
| Breast augmentation | $4,294 |
| Breast lift (mastopexy) | $5,817 |
| Liposuction | $4,449 |
| Tummy tuck (abdominoplasty) | $7,215 |
| Nose reshaping (rhinoplasty) | $6,324 |
| Eyelid surgery (blepharoplasty) | $3,339 |
| Facelift | $9,281 |
| Botulinum toxin injection | $528 |
| Hyaluronic acid filler | $794 |
National average surgeon/physician fee. Excludes anesthesia, operating room facilities and other related expenses.
| Age | Surgical | Minimally invasive |
|---|---|---|
| 19 and under | 23,5272% of surgical | 244,2521% of minimally invasive |
| 20 to 29 | 139,3399% of surgical | 899,3834% of minimally invasive |
| 30 to 39 | 362,28925% of surgical | 3,286,50916% of minimally invasive |
| 40 to 54 | 536,55636% of surgical | 9,696,09646% of minimally invasive |
| 55 to 69 | 347,66224% of surgical | 6,527,20731% of minimally invasive |
| 70 and over | 62,1604% of surgical | 548,2903% of minimally invasive |
Women had 93% of cosmetic procedures and men 6%, as published by ASPS (its 2022 gender tables use different bases, so the shares do not add to 100%).
ASPS did not publish a 2021 report. The 2022 release compares 2022 with pre pandemic 2019 and uses a new format: procedures marked by ASPS as member surgeon counts cover ASPS Member Surgeons only, and categories were regrouped, so the totals are not comparable with 2020 and earlier. ASPS did not publish a 2019 comparison for the regrouped minimally invasive categories.
ASPS counted 15,595,955 cosmetic procedures in 2020, down 15% from 2019: 2,314,720 surgical and 13,281,235 minimally invasive. Nose reshaping (rhinoplasty) was the most performed cosmetic surgery (352,555), and botulinum toxin injections led minimally invasive procedures (4,401,536).
| # | Procedure | Procedures |
|---|---|---|
| 1 | Nose reshaping (rhinoplasty) | 352,555down 3% vs 2019 |
| 2 | Eyelid surgery (blepharoplasty) | 325,112down 8% vs 2019 |
| 3 | Facelift | 234,374down 11% vs 2019 |
| 4 | Liposuction | 211,067down 20% vs 2019 |
| 5 | Breast augmentation | 193,073down 33% vs 2019 |
| # | Procedure | Procedures |
|---|---|---|
| 1 | Botulinum toxin injections (Botox, Dysport, Xeomin and similar) | 4,401,536down 13% vs 2019 |
| 2 | Soft tissue fillers | 3,410,730down 11% vs 2019 |
| 3 | Laser skin resurfacing | 997,245down 8% vs 2019 |
| 4 | Chemical peel | 931,473down 33% vs 2019 |
| 5 | Intense pulsed light (IPL) treatment | 827,409down 12% vs 2019 |
| Procedure | Average fee |
|---|---|
| Breast augmentation | $4,516 |
| Breast lift (mastopexy) | $5,012 |
| Liposuction | $3,637 |
| Tummy tuck (abdominoplasty) | $6,154 |
| Nose reshaping (rhinoplasty) | $5,483 |
| Eyelid surgery (blepharoplasty) | $4,120 |
| Facelift | $8,005 |
| Botulinum toxin injection | $466 |
| Hyaluronic acid filler | $684 |
National average surgeon/physician fee. Excludes anesthesia, operating room facilities and other related expenses.
| Age | Procedures | Share |
|---|---|---|
| 13 to 19 | 229,740 | 2% |
| 20 to 29 | 768,546 | 6% |
| 30 to 39 | 2,168,015 | 16% |
| 40 to 54 | 6,152,758 | 45% |
| 55 to 69 | 3,970,191 | 29% |
| 70 and over | 246,566 | 2% |
| Women | 12,436,324 | 92% |
| Men | 1,109,483 | 8% |
ASPS gender and age tables cover 13,545,807 cosmetic procedures with patient demographics reported.
| Group | Procedures | Share |
|---|---|---|
| Caucasian | 10,330,749down 20% vs 2019 | 66% |
| Hispanic | 1,985,351down 4% vs 2019 | 13% |
| African American | 1,781,485no change vs 2019 | 11% |
| Asian American | 1,207,619down 5% vs 2019 | 8% |
| Other | 290,751down 9% vs 2019 | 2% |
COVID 19: physicians reported that they stopped performing surgical procedures for an average of 8.1 weeks in 2020. The 2019 comparison figures are the restated 2019 numbers.
Spending: the 2020 fee tables total $20,174,266,026, while the quick facts page of the same report says $16.7 billion was spent on cosmetic procedures. Both figures are as printed by ASPS.
ASPS's restated 2019 figures count 18,428,665 cosmetic procedures: 2,678,302 surgical and 15,750,363 minimally invasive. Nose reshaping (rhinoplasty) was the most performed cosmetic surgery (362,299), and botulinum toxin injections led minimally invasive procedures (5,043,057).
| # | Procedure | Procedures |
|---|---|---|
| 1 | Nose reshaping (rhinoplasty) | 362,299 |
| 2 | Eyelid surgery (blepharoplasty) | 354,105 |
| 3 | Breast augmentation | 287,085 |
| 4 | Liposuction | 265,209 |
| 5 | Facelift | 261,987 |
| # | Procedure | Procedures |
|---|---|---|
| 1 | Botulinum toxin injections (Botox, Dysport, Xeomin and similar) | 5,043,057 |
| 2 | Soft tissue fillers | 3,816,274 |
| 3 | Chemical peel | 1,387,607 |
| 4 | Laser skin resurfacing | 1,087,887 |
| 5 | Laser hair removal | 1,055,456 |
| Procedure | Average fee |
|---|---|
| Breast augmentation | $4,789 |
| Breast lift (mastopexy) | $4,980 |
| Liposuction | $3,684 |
| Tummy tuck (abdominoplasty) | $6,125 |
| Nose reshaping (rhinoplasty) | $5,437 |
| Eyelid surgery (blepharoplasty) | $4,278 |
| Facelift | $7,944 |
| Botulinum toxin injection | $492 |
| Hyaluronic acid filler | $694 |
National average surgeon/physician fee. Excludes anesthesia, operating room facilities and other related expenses.
These are the 2019 figures as ASPS restated them in 2020, with projections updated to reflect a more comprehensive set of board certified physicians and botulinum toxin counted without adjustment for anatomic sites. This restated report was the 2019 report on the ASPS statistics page until it went offline, and it is the baseline the 2020 and 2022 reports compare against. The restated report does not include year over year changes or age and gender tables. The figures in the originally published 2019 full report were calculated on the earlier basis and differ; they are not transcribed here.
Total spending in the restated 2019 fee tables: $23,731,789,413 in surgeon and physician fees.
ASPS counted 17,721,671 cosmetic procedures in 2018, up 2% from 2017: 1,811,740 surgical and 15,909,931 minimally invasive. Breast augmentation was the most performed cosmetic surgery (313,735), and botulinum toxin injections led minimally invasive procedures (7,437,378).
| # | Procedure | Procedures |
|---|---|---|
| 1 | Breast augmentation | 313,735up 4% vs 2017 |
| 2 | Liposuction | 258,558up 5% vs 2017 |
| 3 | Nose reshaping (rhinoplasty) | 213,780down 2% vs 2017 |
| 4 | Eyelid surgery (blepharoplasty) | 206,529down 1% vs 2017 |
| 5 | Tummy tuck (abdominoplasty) | 130,081no change vs 2017 |
| # | Procedure | Procedures |
|---|---|---|
| 1 | Botulinum toxin injections (Botox, Dysport, Xeomin and similar) | 7,437,378up 3% vs 2017 |
| 2 | Soft tissue fillers | 2,676,970up 2% vs 2017 |
| 3 | Chemical peel | 1,384,327up 1% vs 2017 |
| 4 | Laser hair removal | 1,077,490down 1% vs 2017 |
| 5 | Microdermabrasion | 709,413down 4% vs 2017 |
| Procedure | Average fee |
|---|---|
| Breast augmentation | $3,824 |
| Breast lift (mastopexy) | $4,816 |
| Liposuction | $3,518 |
| Tummy tuck (abdominoplasty) | $6,253 |
| Nose reshaping (rhinoplasty) | $5,350 |
| Eyelid surgery (blepharoplasty) | $3,156 |
| Facelift | $7,655 |
| Botulinum toxin injection | $397 |
| Hyaluronic acid filler | $682 |
National average surgeon/physician fee. Excludes anesthesia, operating room facilities and other related expenses.
| Age | Procedures | Share |
|---|---|---|
| 13 to 19 | 226,994 | 1% |
| 20 to 29 | 831,775 | 5% |
| 30 to 39 | 2,907,650 | 18% |
| 40 to 54 | 7,800,921 | 49% |
| 55 and over | 4,216,425 | 26% |
| Women | 14,676,921 | 92% |
| Men | 1,306,844 | 8% |
ASPS gender and age tables cover 15,983,765 cosmetic procedures with patient demographics reported.
Botulinum toxin figures in this report count anatomic sites injected, as ASPS noted in the report.
Spending: $16,507,440,034 in surgeon and physician fees for cosmetic procedures (the report's quick facts round this to $16.5 billion).
ASPS counted 17,504,950 cosmetic procedures in 2017, up 2% from 2016: 1,790,832 surgical and 15,714,118 minimally invasive. Breast augmentation was the most performed cosmetic surgery (300,378), and botulinum toxin injections led minimally invasive procedures (7,230,967).
| # | Procedure | Procedures |
|---|---|---|
| 1 | Breast augmentation | 300,378up 3% vs 2016 |
| 2 | Liposuction | 246,354up 5% vs 2016 |
| 3 | Nose reshaping (rhinoplasty) | 218,924down 2% vs 2016 |
| 4 | Eyelid surgery (blepharoplasty) | 209,571no change vs 2016 |
| 5 | Tummy tuck (abdominoplasty) | 129,753up 2% vs 2016 |
| # | Procedure | Procedures |
|---|---|---|
| 1 | Botulinum toxin injections (Botox, Dysport, Xeomin and similar) | 7,230,967up 2% vs 2016 |
| 2 | Soft tissue fillers | 2,691,265up 3% vs 2016 |
| 3 | Chemical peel | 1,376,703up 1% vs 2016 |
| 4 | Laser hair removal | 1,086,830down 2% vs 2016 |
| 5 | Microdermabrasion | 740,287down 4% vs 2016 |
| Procedure | Average fee |
|---|---|
| Breast augmentation | $3,718 |
| Breast lift (mastopexy) | $4,672 |
| Liposuction | $3,374 |
| Tummy tuck (abdominoplasty) | $5,992 |
| Nose reshaping (rhinoplasty) | $5,125 |
| Eyelid surgery (blepharoplasty) | $3,026 |
| Facelift | $7,448 |
| Botulinum toxin injection | $385 |
| Hyaluronic acid filler | $682 |
National average surgeon/physician fee. Excludes anesthesia, operating room facilities and other related expenses.
| Age | Procedures | Share |
|---|---|---|
| 13 to 19 | 228,797 | 1% |
| 20 to 29 | 827,347 | 5% |
| 30 to 39 | 2,855,319 | 18% |
| 40 to 54 | 7,737,308 | 49% |
| 55 and over | 4,168,693 | 26% |
| Women | 14,489,746 | 92% |
| Men | 1,327,718 | 8% |
ASPS gender and age tables cover 15,817,464 cosmetic procedures with patient demographics reported.
Botulinum toxin figures in this report count anatomic sites injected, as ASPS noted in the report.
Spending: $16,760,022,499 in surgeon and physician fees for cosmetic procedures (the report's quick facts round this to $16.7 billion).
ASPS counted 17,192,816 cosmetic procedures in 2016, up 3% from 2015: 1,780,987 surgical and 15,411,829 minimally invasive. Breast augmentation was the most performed cosmetic surgery (290,467), and botulinum toxin injections led minimally invasive procedures (7,056,255).
| # | Procedure | Procedures |
|---|---|---|
| 1 | Breast augmentation | 290,467up 4% vs 2015 |
| 2 | Liposuction | 235,237up 6% vs 2015 |
| 3 | Nose reshaping (rhinoplasty) | 223,018up 2% vs 2015 |
| 4 | Eyelid surgery (blepharoplasty) | 209,020up 2% vs 2015 |
| 5 | Facelift | 131,106up 4% vs 2015 |
| # | Procedure | Procedures |
|---|---|---|
| 1 | Botulinum toxin injections (Botox, Dysport, Xeomin and similar) | 7,056,255up 4% vs 2015 |
| 2 | Soft tissue fillers | 2,600,868up 2% vs 2015 |
| 3 | Chemical peel | 1,360,850up 4% vs 2015 |
| 4 | Laser hair removal | 1,109,385down 1% vs 2015 |
| 5 | Microdermabrasion | 775,014down 3% vs 2015 |
| Procedure | Average fee |
|---|---|
| Breast augmentation | $3,719 |
| Breast lift (mastopexy) | $4,636 |
| Liposuction | $3,200 |
| Tummy tuck (abdominoplasty) | $5,798 |
| Nose reshaping (rhinoplasty) | $5,046 |
| Eyelid surgery (blepharoplasty) | $3,022 |
| Facelift | $7,048 |
| Botulinum toxin injection | $385 |
| Hyaluronic acid filler | $644 |
National average surgeon/physician fee. Excludes anesthesia, operating room facilities and other related expenses.
| Age | Procedures | Share |
|---|---|---|
| 13 to 19 | 229,551 | 1% |
| 20 to 29 | 828,997 | 5% |
| 30 to 39 | 2,810,377 | 18% |
| 40 to 54 | 7,618,671 | 49% |
| 55 and over | 4,097,276 | 26% |
| Women | 14,269,280 | 92% |
| Men | 1,315,592 | 8% |
ASPS gender and age tables cover 15,584,872 cosmetic procedures with patient demographics reported.
Botulinum toxin figures in this report count anatomic sites injected, as ASPS noted in the report.
Spending: $16,438,680,911 in surgeon and physician fees for cosmetic procedures (the report's quick facts round this to $16.4 billion).
ASPS counted 15,908,330 cosmetic procedures in 2015, up 2% from 2014: 1,706,106 surgical and 14,202,224 minimally invasive. Breast augmentation was the most performed cosmetic surgery (279,143), and botulinum toxin injections led minimally invasive procedures (6,757,198).
| # | Procedure | Procedures |
|---|---|---|
| 1 | Breast augmentation | 279,143down 2% vs 2014 |
| 2 | Liposuction | 222,051up 5% vs 2014 |
| 3 | Nose reshaping (rhinoplasty) | 217,979no change vs 2014 |
| 4 | Eyelid surgery (blepharoplasty) | 203,934down 1% vs 2014 |
| 5 | Tummy tuck (abdominoplasty) | 127,967up 9% vs 2014 |
| # | Procedure | Procedures |
|---|---|---|
| 1 | Botulinum toxin injections (Botox, Dysport, Xeomin and similar) | 6,757,198up 1% vs 2014 |
| 2 | Soft tissue fillers | 2,440,724up 6% vs 2014 |
| 3 | Chemical peel | 1,310,252up 5% vs 2014 |
| 4 | Laser hair removal | 1,116,708no change vs 2014 |
| 5 | Microdermabrasion | 800,340down 9% vs 2014 |
| Procedure | Average fee |
|---|---|
| Breast augmentation | $3,822 |
| Breast lift (mastopexy) | $4,419 |
| Liposuction | $3,009 |
| Tummy tuck (abdominoplasty) | $5,502 |
| Nose reshaping (rhinoplasty) | $4,771 |
| Eyelid surgery (blepharoplasty) | $2,880 |
| Facelift | $6,652 |
| Botulinum toxin injection | $382 |
| Hyaluronic acid filler | $613 |
National average surgeon/physician fee. Excludes anesthesia, operating room facilities and other related expenses.
| Age | Procedures | Share |
|---|---|---|
| 13 to 19 | 226,170 | 1% |
| 20 to 29 | 815,872 | 5% |
| 30 to 39 | 2,714,439 | 18% |
| 40 to 54 | 7,393,200 | 49% |
| 55 and over | 3,983,443 | 26% |
| Women | 13,854,697 | 92% |
| Men | 1,278,427 | 8% |
ASPS gender and age tables cover 15,133,124 cosmetic procedures with patient demographics reported.
Botulinum toxin figures in this report count anatomic sites injected, as ASPS noted in the report.
Spending: $13,383,178,199 in surgeon and physician fees for cosmetic procedures (the report's quick facts round this to $13.3 billion).
ASPS counted 15,622,866 cosmetic procedures in 2014, up 3% from 2013: 1,677,478 surgical and 13,945,388 minimally invasive. Breast augmentation was the most performed cosmetic surgery (286,254), and botulinum toxin injections led minimally invasive procedures (6,673,608).
| # | Procedure | Procedures |
|---|---|---|
| 1 | Breast augmentation | 286,254down 1% vs 2013 |
| 2 | Nose reshaping (rhinoplasty) | 217,124down 2% vs 2013 |
| 3 | Liposuction | 210,552up 5% vs 2013 |
| 4 | Eyelid surgery (blepharoplasty) | 206,509down 4% vs 2013 |
| 5 | Facelift | 128,266down 4% vs 2013 |
| # | Procedure | Procedures |
|---|---|---|
| 1 | Botulinum toxin injections (Botox, Dysport, Xeomin and similar) | 6,673,608up 6% vs 2013 |
| 2 | Soft tissue fillers | 2,301,673up 3% vs 2013 |
| 3 | Chemical peel | 1,250,059up 7% vs 2013 |
| 4 | Laser hair removal | 1,112,046up 3% vs 2013 |
| 5 | Microdermabrasion | 881,905down 9% vs 2013 |
| Procedure | Average fee |
|---|---|
| Breast augmentation | $3,708 |
| Breast lift (mastopexy) | $4,377 |
| Liposuction | $2,971 |
| Tummy tuck (abdominoplasty) | $5,493 |
| Nose reshaping (rhinoplasty) | $4,694 |
| Eyelid surgery (blepharoplasty) | $2,874 |
| Facelift | $6,550 |
| Botulinum toxin injection | $371 |
| Hyaluronic acid filler | $590 |
National average surgeon/physician fee. Excludes anesthesia, operating room facilities and other related expenses.
| Age | Procedures | Share |
|---|---|---|
| 13 to 19 | 224,079 | 2% |
| 20 to 29 | 815,145 | 5% |
| 30 to 39 | 2,686,017 | 18% |
| 40 to 54 | 7,236,197 | 49% |
| 55 and over | 3,913,596 | 26% |
| Women | 13,613,231 | 92% |
| Men | 1,261,803 | 8% |
ASPS gender and age tables cover 14,875,034 cosmetic procedures with patient demographics reported.
Botulinum toxin figures in this report count anatomic sites injected, as ASPS noted in the report.
Spending: $12,927,615,364 in surgeon and physician fees for cosmetic procedures (the report's quick facts round this to $12.9 billion).
ASPS counted 15,116,353 cosmetic procedures in 2013, up 3% from 2012: 1,668,420 surgical and 13,447,933 minimally invasive. Breast augmentation was the most performed cosmetic surgery (290,224), and botulinum toxin injections led minimally invasive procedures (6,321,160).
| # | Procedure | Procedures |
|---|---|---|
| 1 | Breast augmentation | 290,224up 1% vs 2012 |
| 2 | Nose reshaping (rhinoplasty) | 221,053down 9% vs 2012 |
| 3 | Eyelid surgery (blepharoplasty) | 215,641up 6% vs 2012 |
| 4 | Liposuction | 199,817down 1% vs 2012 |
| 5 | Facelift | 133,320up 6% vs 2012 |
| # | Procedure | Procedures |
|---|---|---|
| 1 | Botulinum toxin injections (Botox, Dysport, Xeomin and similar) | 6,321,160up 3% vs 2012 |
| 2 | Soft tissue fillers | 2,242,621up 13% vs 2012 |
| 3 | Chemical peel | 1,163,333up 3% vs 2012 |
| 4 | Laser hair removal | 1,077,158down 4% vs 2012 |
| 5 | Microdermabrasion | 970,343no change vs 2012 |
| Procedure | Average fee |
|---|---|
| Breast augmentation | $3,678 |
| Breast lift (mastopexy) | $4,207 |
| Liposuction | $2,866 |
| Tummy tuck (abdominoplasty) | $5,217 |
| Nose reshaping (rhinoplasty) | $4,545 |
| Eyelid surgery (blepharoplasty) | $2,818 |
| Facelift | $6,556 |
| Botulinum toxin injection | $380 |
| Hyaluronic acid filler | $568 |
National average surgeon/physician fee. Excludes anesthesia, operating room facilities and other related expenses.
| Age | Procedures | Share |
|---|---|---|
| 13 to 19 | 219,564 | 2% |
| 20 to 29 | 801,753 | 6% |
| 30 to 39 | 2,596,482 | 18% |
| 40 to 54 | 6,993,052 | 49% |
| 55 and over | 3,778,413 | 26% |
| Women | 13,140,225 | 91% |
| Men | 1,249,039 | 9% |
ASPS gender and age tables cover 14,389,264 cosmetic procedures with patient demographics reported.
Botulinum toxin figures in this report count anatomic sites injected, as ASPS noted in the report.
Spending: $12,631,581,051 in surgeon and physician fees for cosmetic procedures (the report's quick facts round this to $12.6 billion).
2013 to 2018: ASPS surveyed board certified physicians (more than 24,500 were sent the 2018 questionnaire), combined the replies with its Tracking Operations and Outcomes for Plastic Surgeons database, and projected the results to all physicians most likely to perform these procedures. Botulinum toxin figures in these reports count anatomic sites injected.
2019 and 2020: ASPS updated its projections to reflect a broader set of board certified physicians and restated 2019 on that basis, counting botulinum toxin without the anatomic site adjustment. That is why the 2019 figures here (18.4 million cosmetic procedures) are higher than the 2018 report's.
2022 onward: After skipping 2021, ASPS moved to a new format. Most surgical procedures are counted from ASPS member surgeons only, procedure categories were regrouped (for example skin resurfacing and laser skin treatments), minimally invasive counts include non member dermatologists and otolaryngologists, and the 2022 report compares against 2019. In 2024 ASPS began publishing surgeon fees as a projected range instead of a single average.
The practical rule: compare years within the same method. For long run trends in a single procedure, see our data stories on age demographics, the post COVID boom and what cosmetic surgery really costs.
The American Society of Plastic Surgeons has taken its archive of annual Plastic Surgery Statistics Reports and the press releases that announced them offline, so links to the original PDFs on plasticsurgery.org now return a page not found error. This page preserves the headline figures from each report from 2013 to 2024, transcribed from the original PDFs, and links to the Internet Archive copy of each original where one exists.
ASPS counted 15,595,955 cosmetic procedures in 2020, down 15% from 18,428,665 in 2019. That included 2,314,720 cosmetic surgical procedures and 13,281,235 minimally invasive procedures. Physicians reported stopping surgical procedures for an average of 8.1 weeks in 2020 because of COVID 19.
Liposuction has been the most performed cosmetic surgery in the ASPS reports for 2022, 2023 and 2024, with 349,728 procedures in 2024, followed by breast augmentation (306,196). In the 2013 to 2018 reports breast augmentation was the top cosmetic surgical procedure every year, and in the restated 2019 figures and in 2020 nose reshaping ranked first.
ASPS reported 9,883,711 neuromodulator injections (Botox, Dysport, Xeomin, Jeuveau and Daxxify) in 2024, up 4% from 9,480,949 in 2023. Under the older method, which counted anatomic sites injected, the 2018 report listed 7,437,378 botulinum toxin procedures.
The ASPS fee tables put total 2018 spending on cosmetic procedures at $16,507,440,034, or about $16.5 billion, based on average surgeon and physician fees. The fee tables for 2020 total $20,174,266,026, although the 2020 quick facts page states $16.7 billion. These totals cover surgeon fees only, not anesthesia, operating room or facility costs.
ASPS changed its method with the 2022 report. Most surgical procedures are now counted from ASPS member surgeons only, procedure categories were regrouped, and minimally invasive totals include non member dermatologists and otolaryngologists. The 2022 report compares against 2019 instead of 2021. Compare years within the same method, not across the change.
No. ASPS did not publish an annual statistics report for 2021. Its 2022 report compared 2022 with the pre pandemic year of 2019.
Yes. The figures are facts from the American Society of Plastic Surgeons, so cite ASPS and the report year as the source. You are welcome to link to this page, or to the per year section (for example /resources/plastic-surgery-statistics#2020), as an accessible copy of the headline figures. Where the Internet Archive holds a copy of the original PDF, we link to it in each year’s sources.
NavMDs lists thousands of aesthetic doctors with credentials, reviews and real prices. Search by procedure and city.
Find a doctor